Literature DB >> 15734887

Delineating the guide-wire flow obstruction effect in assessment of fractional flow reserve and coronary flow reserve measurements.

Abhijit Sinha Roy1, Rupak K Banerjee, Lloyd H Back, Martin R Back, Saeb Khoury, Ronald W Millard.   

Abstract

Hemodynamic analysis was conducted to determine uncertainty in clinical measurements of coronary flow reserve (CFR) and fractional flow reserve (FFR) over pathophysiological conditions in a patient group with coronary artery disease during angioplasty. The vasodilation-distal perfusion pressure (CFR-p(rh)) curve was obtained for 0.35- and 0.46-mm guide wires. Our hypothesis is that a guide wire spanning the lesions elevates the pressure gradient and reduces the flow during hyperemic measurements. Maximal CFR-p(rh) was uniquely determined by the intersection of measured CFR and calculated p(rh) of native and residual epicardial lesions in patients without microvascular disease, during angioplasty. Extrapolation of the linear curve gave a zero-coronary flow mean pressure (p(zf)) of approximately 20 mmHg and a corresponding p(rh) of 55 mmHg in the native lesions, which coincided with the level that causes ischemia in human hearts. On this linear curve, values of CFR and FFRmyo (pathophysiological condition) and CFRg and FFRmyog (in the presence of the guide wire) were obtained in native and residual lesions. A strong linear correlation was found between CFR and CFRg [CFR = CFRg x 0.689 + 1.271 (R2= 0.99) for 0.46 mm and CFR = CFRg x 0.757 + 1.004 (R2= 0.99) for 0.35 mm] and between FFRmyo and FFRmyog [FFRmyo = FFRmyog x 0.737 + 0.263 (R2= 0.99) for 0.46 mm and FFRmyo = FFRmyog x 0.790 + 0.210 (R2= 0.99) for 0.35 mm]. This study establishes a strong correlation between CFR and CFRg and between FFRmyo and FFRmyog, which could be used to obtain the true state of occlusion in the coronary artery during angioplasty.

Entities:  

Mesh:

Year:  2005        PMID: 15734887     DOI: 10.1152/ajpheart.00798.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

Review 1.  Combined functional and anatomical diagnostic endpoints for assessing arteriovenous fistula dysfunction.

Authors:  Ehsan Rajabi-Jaghargh; Rupak K Banerjee
Journal:  World J Nephrol       Date:  2015-02-06

2.  Optimization of intravascular shear stress assessment in vivo.

Authors:  Lisong Ai; Hongyu Yu; Wakako Takabe; Anna Paraboschi; Fei Yu; E S Kim; Rongsong Li; Tzung K Hsiai
Journal:  J Biomech       Date:  2009-05-19       Impact factor: 2.712

3.  Real-time intravascular shear stress in the rabbit abdominal aorta.

Authors:  Lisong Ai; Hongyu Yu; Wangde Dai; Sharon L Hale; Robert A Kloner; Tzung K Hsiai
Journal:  IEEE Trans Biomed Eng       Date:  2009-06       Impact factor: 4.538

4.  Effect of guidewire on contribution of loss due to momentum change and viscous loss to the translesional pressure drop across coronary artery stenosis: an analytical approach.

Authors:  Ehsan Rajabi-Jaghargh; Kranthi K Kolli; Lloyd H Back; Rupak K Banerjee
Journal:  Biomed Eng Online       Date:  2011-06-10       Impact factor: 2.819

5.  Improved Functional Assessment of Ischemic Severity Using 3D Printed Models.

Authors:  Kranthi K Kolli; Sun-Joo Jang; Abdul Zahid; Alexandre Caprio; Seyedhamidreza Alaie; Amir Ali Amiri Moghadam; Patricia Xu; Robert Shepherd; Bobak Mosadegh; Simon Dunham
Journal:  Front Cardiovasc Med       Date:  2022-06-30

6.  Hemodynamic diagnostics of epicardial coronary stenoses: in-vitro experimental and computational study.

Authors:  Rupak K Banerjee; Koustubh D Ashtekar; Tarek A Helmy; Mohamed A Effat; Lloyd H Back; Saeb F Khoury
Journal:  Biomed Eng Online       Date:  2008-08-27       Impact factor: 2.819

7.  Effect of Varying Hemodynamic and Vascular Conditions on Fractional Flow Reserve: An In Vitro Study.

Authors:  Kranthi K Kolli; James K Min; Seongmin Ha; Hilary Soohoo; Guanglei Xiong
Journal:  J Am Heart Assoc       Date:  2016-06-30       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.